Enhanced LDHA expression has been related to tumour aggressiveness (i.e. promoting angiogenesis, immune evasion, extracellular matrix degradation, and tumour cell migration) as well as metastatic disease [41], and has therefore been proposed as a potential promising prognostic biomarker for cancers [42]. The gene discussed is LDHA; the disease is cancer.